6 results
Benign Prostatic Hyperplasia: Pathogenesis and Medications
Aging
 -> Increased Testosterone -> Testosterone metabolized into DHT by type
Benign Prostatic ... inflammation #BPH ... #Benign #Prostatic ... #Pathophysiology ... #Medications #Pharmacology
Pharmacology and differences between medications for treating benign prostate hyperplasia (BPH).

#bph #pharmacology #medications #management #prostate
Pharmacology and ... medications for treating benign ... prostate hyperplasia ... (BPH). ... #bph #pharmacology
Antibiotic Tissue Penetration

Blood Brain Barrier: Penicilins (IV), 3rd & 4th generation Cephalosporins (IV), Meropenem, TMP-SMX, Metronidazole,
Antibiotic Tissue ... Fluoroquinolones Prostate ... Lungs: Most antibiotics ... inactivated by low pH ... #Penetration #pharmacology
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
Therapy for Benign ... (BPH) 5 Alpha-Reductase ... #Benign #Prostatic ... #Hyperplasia #BPH ... #Pharmacology
Benign Prostatic Hyperplasia: Pathogenesis and Clinical Findings

Hormonal alterations (result of aging process)
    ->
Benign Prostatic ... to ERs in the prostate ... bladder stones #BPH ... #Benign #Prostatic ... #Pathophysiology
Benzodiazepine (BZD) withdrawal: clinical findings and complications

 • Activation of ACC and OFC -> Feelings of
Asthma. or sense of being ... Activity -> Incr BP ... BZD #withdrawal #pharmacology ... #pathophysiology